High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease

Neurobiol Dis. 2014 Apr:64:60-5. doi: 10.1016/j.nbd.2013.12.005. Epub 2013 Dec 17.

Abstract

Objective: Oscillatory activity in the beta band is increased in the subthalamic nucleus (STN) of Parkinson's disease (PD) patients. Rigidity and bradykinesia are associated with the low-beta component (13-20Hz) but the neurophysiological correlate of freezing of gait in PD has not been ascertained.

Methods: We evaluated the power and coherence of the low- and high-beta bands in the STN and cortex (EEG) of PD patients with (p-FOG) (n=14) or without freezing of gait (n-FOG) (n=8) in whom electrodes for chronic stimulation in the STN had been implanted for treatment with deep brain stimulation.

Results: p-FOG patients showed higher power in the high-beta band (F=11.6, p=0.002) that was significantly reduced after l-dopa administration along with suppression of FOG (F=4.6, p=0.042). High-beta cortico-STN coherence was maximal for midline cortical EEG electrodes, whereas the low-beta band was maximal for lateral electrodes (χ(2)=20.60, p<0.0001).

Conclusions: The association between freezing of gait, high-beta STN oscillations and cortico-STN coherence suggests that this oscillatory activity might interfere in the frontal cortex-basal ganglia networks, thereby participating in the pathophysiology of FOG in PD.

Keywords: Beta activity; Freezing of gait; Oscillatory activity; Parkinson's disease; Subthalamic nucleus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparkinson Agents / therapeutic use
  • Beta Rhythm / drug effects
  • Beta Rhythm / physiology*
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / physiopathology
  • Deep Brain Stimulation
  • Electroencephalography
  • Female
  • Gait Apraxia / drug therapy
  • Gait Apraxia / etiology*
  • Gait Apraxia / physiopathology*
  • Gait Apraxia / therapy
  • Humans
  • Implantable Neurostimulators
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Neural Pathways / drug effects
  • Neural Pathways / physiopathology
  • Parkinson Disease / complications*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / physiopathology*
  • Parkinson Disease / therapy
  • Subthalamic Nucleus / drug effects
  • Subthalamic Nucleus / physiopathology*

Substances

  • Antiparkinson Agents
  • Levodopa